ArticleMolecular pharmaceutics2021

PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models.

Thomas Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.